Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 12, 2018

View Archived Issues

Psoriasis and plaques

Small-molecule inhibitor of urokinase plasminogen activator ameliorates multiple sclerosis in mice

Small-molecule hepcidin production inhibitor developed for treatment of anemia of chronic disease

Novel RORgammat inhibitors developed by Shionogi for treating Th17-mediated autoimmune diseases

Interaction partner identification finds Myc's friends, and vulnerabilities

Seal Rock Therapeutics announces preclinical data for SRT-015 in NASH

CRISPR Therapeutics and MaxCyte expand clinical and commercial license agreement into oncology

Shanghai Jiongshuo Pharmaceutical Technology identifies CDK9/cyclin T1 inhibitors

FDA grants accelerated approval to Keytruda for HCC previously treated with sorafenib

GlaxoSmithKline patents PI3K inhibitors

FDA approves Yupelri for maintenance treatment of COPD

FDA issues EUA for DPP Ebola Antigen System

Harpoon Therapeutics to use series C proceeds to support cancer immunotherapy pipeline

New phase III trial investigates emixustat in macular atrophy secondary to Stargardt disease

Retrotope begins phase II/III study of RT-001 in infantile neuroaxonal dystrophy

Phase I data on BBT-401 pave way for phase II ulcerative colitis study

Adjunctive LHW-090 safely lowers blood pressure in patients with resistant hypertension

Purinergic receptor mutations cause congenital neurogenic bladder

Mutations in DKGE cause C3 glomerulopathy

Combination of IDLV-SIV-Gag and IDLV-PGT121 results in prolonged virus control in vivo

SCaV11 immunogen selectively elicits CD8+ T cells but not CD4+ T cells targeting viral antigens

Genetic determinants of cortical thickness in Alzheimer's disease revealed

Activation of the cellular stress response protects cells from neurotoxicity in Parkinson's disease

Gilead presents first-in-human data for GS-9688 at The Liver Meeting

PACAP/PAC1 signaling protects retinal neurons from death in mice with multiple sclerosis

Sierra completes IND filing for phase I/II trial of SRA-141 in colorectal cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...